2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC3038
  



  

  
Submitter : 
  

  
Mrs. Andrea Sims
  

  
Date & Time: 
  

  
12/12/2006 09:12:28
  



  

  
Organization : 
  

  
Mrs. Andrea Sims
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 Ms. Andrea L. Sims

18603 US HWY 6

Princeton, IL 61356



December 11, 2006 



Division of Dockets Management HFA-305

Food & Drug Administration

5630 Fishers Lane Room 1061

Rockville, MD  20852

Phone:  301 827-5101

Ref: Docket Number 2006D-0383:

Guidance to Industry for Development of Cell-Based Viral Vaccines 



Dear FDA:



I am writing in response to the FDA's invitation to the public to comment on Docket 2006D-0383. I would like to urge the prohibition of the use of aborted fetal cell lines in the production of vaccines. There are many other sources of vaccines, and the use of aborted fetal cells for medical advancement is unethical.  



Sincerely,



Andrea L. Sims